Stock listing

OTC:IPIX Innovation Pharmaceuticals Inc. Stock

Follow Innovation Pharmaceuticals Inc. into a list and get an email when it puts out news.

Share price · OTC:IPIX

$0.0002 USD 0.0000 (0.0%)

Close on Nov 20, 2026

Past year -75.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDNov 20, 2026
Volume
32,842 sharesNov 20, 2026
Market cap
$102,803 USDAt the close on Nov 20, 2026 · price × 514.0M shares outstanding
52-week range
$0.0001 – $0.0500 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$133 USDMedian day 63,438 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Innovation Pharmaceuticals Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:IPIX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.000232,842
$0.00020.00000.0%$0.0002$0.0002$0.000214,833
$0.0002-0.0003-60.0%$0.0005$0.0010$0.0002483,570
$0.0005+0.0003+150.0%$0.0002$0.0006$0.0002214,380
$0.0002-0.0003-60.0%$0.0005$0.0014$0.0002454,641
$0.0005+0.0003+150.0%$0.0005$0.0005$0.000518,000
$0.00020.00000.0%$0.0002$0.0002$0.00026,180
$0.00020.00000.0%$0.0002$0.0002$0.000234,386
$0.0002-0.0003-60.0%$0.0002$0.0002$0.000247,503
$0.0005-0.0003-37.5%$0.0001$0.0010$0.0001657,142
$0.0008+0.0006+300.0%$0.0010$0.0018$0.000190,127
$0.00020.00000.0%$0.0010$0.0010$0.0002153,400
$0.00020.00000.0%$0.0002$0.0016$0.0002442,333
$0.00020.00000.0%$0.0002$0.0002$0.00023,226
$0.00020.00000.0%$0.0002$0.0002$0.00021,000
$0.00020.00000.0%$0.0002$0.0002$0.00022,500
$0.0002-0.0008-80.0%$0.0002$0.0002$0.0002125,000
$0.0010+0.0003+42.9%$0.0009$0.0010$0.00021,505,425
$0.0007+0.0001+16.7%$0.0007$0.0007$0.0007133,500
$0.0006+0.0001+20.0%$0.0006$0.0006$0.00051,082,895
$0.0005+0.0002+66.7%$0.0001$0.0005$0.00011,093,979
$0.0003+0.0001+50.0%$0.0002$0.0003$0.000274,582
$0.00020.00000.0%$0.0002$0.0002$0.0002122,691
$0.00020.00000.0%$0.0001$0.0002$0.0001114,800
$0.00020.00000.0%$0.0002$0.0002$0.0002150,000
$0.00020.00000.0%$0.0002$0.0018$0.000269,425
$0.00020.00000.0%$0.0002$0.0002$0.00027,500
$0.00020.00000.0%$0.0002$0.0002$0.00028,932
$0.0002-0.0003-60.0%$0.0010$0.0020$0.000275,311
$0.0005+0.0003+150.0%$0.0002$0.0005$0.0002194,161
$0.00020.00000.0%$0.0015$0.0020$0.0002108,000
$0.0002+0.0001+100.0%$0.0001$0.0020$0.0001231,810
$0.00010.00000.0%$0.0001$0.0001$0.00013,700
$0.0001-0.0001-50.0%$0.0001$0.0001$0.000157,451
$0.00020.00000.0%$0.0002$0.0002$0.000225,200
$0.00020.00000.0%$0.0020$0.0020$0.00021,100
$0.0002-0.0008-80.0%$0.0002$0.0002$0.0002140
$0.0010+0.0007+233.3%$0.0010$0.0010$0.0010284,981
$0.00030.00000.0%$0.0024$0.0024$0.0003416,100
$0.00030.00000.0%$0.0003$0.0003$0.000317,918
$0.00030.00000.0%$0.0026$0.0026$0.000346,769
$0.00030.00000.0%$0.0003$0.0003$0.000357,304
$0.00030.00000.0%$0.0003$0.0003$0.0003210
$0.00030.00000.0%$0.0003$0.0003$0.00031,000
$0.00030.00000.0%$0.0020$0.0020$0.0003600,100
$0.00030.00000.0%$0.0001$0.0003$0.000123,030
$0.0003-0.0017-85.0%$0.0026$0.0026$0.0003805,100
$0.0020+0.0012+150.0%$0.0003$0.0020$0.0003290,000
$0.0008-0.0007-46.7%$0.0001$0.0030$0.000146,411
$0.00150.00000.0%$0.0015$0.0028$0.001552,327
$0.0015+0.0011+275.0%$0.0004$0.0030$0.00041,094,860
$0.0004-0.0002-33.3%$0.0004$0.0007$0.000419,780
$0.0006+0.0002+50.0%$0.0006$0.0006$0.000412,300
$0.00040.00000.0%$0.0004$0.0004$0.000410,075
$0.00040.00000.0%$0.0004$0.0004$0.000413,000
$0.0004-0.0001-20.0%$0.0026$0.0026$0.0004541,632
Ticker
OTC:IPIX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

All Innovation Pharmaceuticals Inc. news

Innovation Pharmaceuticals Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
192 in all · newest Apr 17, 2023 · oldest 2016
Decks
3 decks · latest September 2022

Valuation

price Nov 20, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.51

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Innovation Pharmaceuticals Inc. · OTC:IPIXUS$102,803n/an/an/an/an/an/an/a0.51
Vaxil Bio Ltd. · TSXV:VXLUS$319,477−US$4,0711.2×n/an/a0.4×n/a0.0×-0.16
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
Median of the othersUS$192,289US$73,5101.2×18.5×0.2×−382.1%0.0×1.14

Team and board

Officers

OfficerRole
Leo EhrlichChief Executive Officer, Chief Financial Officer; Board Chairman
Jane HarnessSenior Vice President, Clinical Sciences and Portfolio Management

Board

DirectorRole
Leo EhrlichChief Executive Officer, Chief Financial Officer; Board Chairman
Barry SchechterIndependent Board Member
Zorik SpektorIndependent Board Member

Events

QuarterResultsShare move
Q1 2024Nov 20, 2023 · After close−16.7%
Q4 2023Sep 28, 2023 · Before open0.0%
Q3 2023May 15, 2023 · Before open0.0%
Q2 2023Feb 15, 2023 · After close0.0%
Q1 2023Nov 10, 2022 · After close0.0%
Q4 2022Sep 28, 2022 · After close0.0%
Q3 2022May 13, 2022 · After close0.0%
Q2 2022Feb 14, 2022 · After close0.0%
Q1 2022Nov 9, 2021 · After close−10.8%
Q4 2021Sep 27, 2021 · After close0.0%
All 12 quarters
QuarterResultsShare move
Q3 2021May 13, 2021 · Before open+5.6%
Q2 2021Feb 22, 2021 · After close−5.1%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2022)Investor deck14 slidesSeptember 2022
Medical Dermatology Therapeutic R&D and Technical Innovation Workshop 2016Conference16 slidesNov 30, 2017
Technical Presentation (July 2017)Technical23 slidesJul 13, 2017

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue18.0K18.0K23.0K423.0K000000
Cost of revenue373.0K382.0K378.0K371.0K413.0K406.0K420.0K00
Gross profit-373.0K18.0K-378.0K423.0K-371.0K-413.0K-406.0K-420.0K00
Research and development1.46M4.81M6.64M2.79M4.34M11.4M12.8M8.95M10.5M6.34M
Selling, general and administrative995.0K1.96M2.00M2.27M2.11M2.58M2.55M3.05M2.42M1.69M
Operating income-172.0K-6.92M-9.02M-4.63M-6.45M-13.9M-15.3M-12.7M-13.0M-8.04M
Depreciation and amortization373.0K382.0K378.0K373.0K371.0K413.0K405.0K420.0K404.0K289.0K
EBITDA201.0K-6.54M-8.64M-4.26M-6.08M-13.5M-14.9M-12.2M-12.6M-7.75M
Interest expense28.0K115.0K4.86M260.0K2.20M202.0K202.0K202.0K202.0K210.0K
Income before tax-3.17M-7.04M-13.9M-6.65M-8.68M-16.4M-15.5M-12.9M-13.1M-8.25M
Income tax172.0K120.0K4.86M362.0K390.0K-2.22M198.0K202.0K202.0K1.00K
Net income-3.17M-7.04M-13.9M-6.65M-9.07M-16.4M-15.5M-12.9M-13.1M-8.25M
Earnings per share, basic-0.01-0.01-0.04-0.03-0.05-0.11-0.12-0.11-0.11-0.08

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents1.52M3.81M10.2M6.02M579.0K2.42M4.14M6.31M8.41M4.99M
Short-term investments78.0K
Receivables29.0K26.0K26.0K12.0K
Inventory49.0K-26.0K-26.0K-12.0K
Current assets1.63M3.95M10.7M6.11M625.0K2.60M4.47M6.69M8.77M5.56M
Property, plant and equipment1.00K2.00K120.0K90.0K38.0K39.0K
Total assets7.52M10.4M14.3M9.25M4.05M6.54M9.11M11.4M14.3M10.9M
Accounts payable1.50M1.08M1.08M557.0K641.0K1.68M105.0K57.0K1.84M43.0K
Current liabilities5.02M4.81M6.54M7.37M7.30M8.69M10.6M8.48M7.29M9.65M
Long-term debt879.0K
Total debt725.0K1.29M1.87M2.46M1.92M2.02M2.02M2.02M2.02M2.02M
Total liabilities5.48M5.65M6.79M7.79M8.18M8.69M10.6M8.48M7.29M9.65M
Shareholders' equity2.04M4.73M7.51M1.46M-4.13M-2.15M-1.46M2.96M7.02M1.21M
Shares outstanding505.8M503.9M386.2M237.3M178.2M144.5M127.3M119.9M115.1M105.0M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-2.11M-6.28M-9.49M-4.16M-6.33M-13.3M-11.7M-9.89M-13.1M-7.51M
Capital spending-60.0K-80.0K-72.0K-91.0K-86.0K-117.0K-336.0K-414.0K-459.0K-2.67M
Free cash flow-2.17M-6.36M-9.57M-4.25M-6.42M-13.4M-12.0M-10.3M-13.5M-10.2M
Cash from investing-60.0K-4.08M-72.0K-91.0K-46.0K-104.0K-336.0K-414.0K-459.0K-2.65M
Cash from financing-123.0K3.97M13.7M9.69M4.53M11.7M9.88M8.20M17.0M12.2M
Dividends paid-86.0K-86.0K-86.0K-9.82M-4.62M
Share buybacks0-670.0K-55.0K-91.0K-172.0K-220.0K8.20M17.0M12.5M
Change in cash-2.29M-6.39M4.18M5.44M-1.84M-1.72M-2.17M-2.10M3.42M2.03M

Open Financials

Cap table

Built by 6ix from Innovation Pharmaceuticals Inc.’s releases

Common shares
514,013,755
Fully diluted
514,013,755

Fully diluted

LineShares
Common shares514,013,755

Share count over time

CountShares
Nov 22, 2026514,013,755

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Arthur Peter Bertolino
Other companies: Cellceutix Corp (Pres. & Chief Medical Officer · Jun 30, 2016 – Jun 30, 2016 · Past); Revance Therapeutics, Inc. (EVP and Chief Medical Officer · Sep 2, 2014 – Nov 17, 2015 · Past)
President and CMO, Director · Jun 30, 2017 – Sep 1, 2019 · Past
Barry SchecHter
Other companies: Cellceutix Corp (Director · Jun 10, 2016 – Jul 7, 2016 · Past)
Independent Board Member · Since at least Sep 28, 2022
Leo Ehrlich
Other companies: Cellceutix Corp (Chief Executive Officer, Director · Jul 30, 2012 – Dec 30, 2014 · Past)
Chief Executive Officer, Chief Financial Officer; Board Chairman · Since at least Jun 30, 2017
Zorik Spektor
Other companies: Cellceutix Corp (Director · Jun 10, 2016 – Jul 11, 2016 · Past)
Independent Board Member · Since at least Sep 28, 2022
Jane HarnessSenior Vice President, Clinical Sciences and Portfolio Management · Since at least Aug 30, 2016

Open People

Log in to ask 6ix AI your own questions about Innovation Pharmaceuticals Inc.